Financial Sector Equities Under Review -- HCP Inc., Medical Properties Trust, Capstead Mortgage, and New York Mortgage Trust

Jul 28, 2016, 09:00 ET from Chelmsford Park SA

NEW YORK, July 28, 2016 /PRNewswire/ --

2016 continues to present a wave of challenges to the Financials sector, which has been on a roller-coaster ride since the beginning of the year. Several names, however, remain impressive as the industry works to adapt to the evolving market and reshape itself.  Ahead of today's session, takes a closer look at four companies in this space: HCP Inc. (NYSE: HCP), Medical Properties Trust Inc. (NYSE: MPW), Capstead Mortgage Corp. (NYSE: CMO), and New York Mortgage Trust Inc. (NASDAQ: NYMT). Learn more about these stocks by accessing their freenotes at:

HCP Inc. 

Shares in Irvine, California-based HCP Inc. ended Wednesday's session 0.39% lower at $38.67 with a total volume of 2.78 million shares traded. The stock has advanced 13.14% in the last month; 14.84% over the previous three months; and 4.43% on an YTD basis. The Company's shares are trading 10.47% above their 50-day moving average and 13.60% above their 200-day moving average. Moreover, shares of HCP Inc.'s, which invests in real estate markets of the U.S., have Relative Strength Index (RSI) of 72.63.

On July 11th, 2016, HCP Inc. announced that its Executive Chairman, Michael D. McKee, has assumed the additional role of interim President and CEO, replacing Lauralee Martin, who has left the Company and its Board. The Board of Directors will initiate the process of appointing a permanent CEO, which is expected to take between three and six months.

On July 26th, 2016, research firm Raymond James initiated an 'Underperform' rating for the Company's stock. HCP complete notes are just a click away at:

Medical Properties Trust 

Birmingham, Alabama-based Medical Properties Trust Inc.'s shares saw a slight drop of 0.77%, closing the day at $15.52 with a total volume of 1.60 million shares traded. The stock has advanced 3.12% in the last month, 16.14% in the previous three months, and 39.38% since the start of this year. The Company's shares are trading 4.53% and 26.01% above their 50-day and 200-day moving averages, respectively. Additionally, shares of Medical Properties Trust, which acquires, develops, and invests in healthcare facilities; and leases healthcare facilities to healthcare operating companies and healthcare providers, have an RSI of 58.08.

On July 14th, 2016, Medical Properties Trust announced that the previously announced public offering of $500 million aggregate principal amount of senior notes due 2026 by its operating partnership, MPT Operating Partnership, L.P., and MPT Finance Corporation, a wholly-owned subsidiary of MPT Operating Partnership was priced with a coupon of 5.250%. The Issuers intend to use approximately $474.3 million of the net proceeds from the offering of the Notes to fund the redemption of all of the $450 million aggregate principal amount of their existing 6.875% Senior Notes due 2021.

On July 22nd, 2016, research firm Deutsche Bank initiated a 'Buy' rating, issuing a target price of $17 on the Company's stock. The complimentary notes on MPW can be accessed at:

Capstead Mortgage 

On Wednesday, shares in Dallas, Texas headquartered Capstead Mortgage Corp. gained 0.20%, closing the session at $10.05. The stock recorded a trading volume of 498,963 shares. The Company's shares have advanced 8.41% in the last one month, 5.42% over the previous three months, and 21.03% on an YTD basis. The stock is trading 4.36% above its 50-day moving average and 9.79% above its 200-day moving average. Furthermore, shares of Capstead Mortgage, which invests in a portfolio of residential mortgage pass-through securities primarily consisting of short-duration adjustable-rate mortgage securities issued and guaranteed by government-sponsored enterprises, or by an agency of the federal government, have an RSI of 66.67.

On July 27th, 2016, Capstead Mortgage announced financial results for the quarter ended June 30th, 2016. Capstead reported net income of $21.6 million, or $0.19 per diluted common share, for the quarter as compared to net income of $27.4 million, or $0.25 per diluted common share, for the quarter ended March 31st, 2016. Sign up for your complimentary notes on CMO at:

New York Mortgage Trust 

New York headquartered New York Mortgage Trust Inc.'s shares finished the session 0.93% higher at $6.52 with a total volume of 544,540 shares traded. The stock has advanced 12.22% in the last month, 25.38% over the previous three months, and 22.33% on YTD basis. The Company's shares are trading above their 50-day and 200-day moving averages by 6.73% and 21.08%, respectively. Additionally, shares of New York Mortgage Trust, which engages in acquiring, investing in, financing, and managing mortgage-related and financial assets in the U.S., have an RSI of 68.90.

On July 20th, 2016, New York Mortgage Trust announced that it will report financial results for the three and six months ended June 30th, 2016 after the close of market on August 2nd, 2016. The company will host a conference call and audio webcast at 9:00 a.m., Eastern Time, on August 3rd, 2016. Get free access to your notes on NYMT at:


Stock Callers: 

Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

SC has not been compensated; directly or indirectly; for producing or publishing this document. 


The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email RohitTuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  


SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 


This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: Phone number:  +44 330 808 3765 Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Chelmsford Park SA